0001209191-19-013268.txt : 20190225
0001209191-19-013268.hdr.sgml : 20190225
20190225200024
ACCESSION NUMBER: 0001209191-19-013268
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190221
FILED AS OF DATE: 20190225
DATE AS OF CHANGE: 20190225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SLATTERY JOSEPH P
CENTRAL INDEX KEY: 0001246530
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 19631267
MAIL ADDRESS:
STREET 1: C/O TRANSENTERIX, INC.
STREET 2: 635 DAVIS DRIVE, SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANSENTERIX INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
FORMER COMPANY:
FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-21
0
0000876378
TRANSENTERIX INC.
TRXC
0001246530
SLATTERY JOSEPH P
C/O TRANSENTERIX, INC.
635 DAVIS DRIVE, SUITE 300
MORRISVILLE
NC
27560
0
1
0
0
EVP and CFO
Common Stock
2019-02-21
4
S
0
17650
3.25
D
44929
D
Common Stock
2019-02-22
4
M
0
26292
1.39
A
71221
D
Common Stock
2019-02-22
4
S
0
71221
3.25
D
0
D
Common Stock
25000
I
By IRA
Stock Option
1.39
2019-02-22
4
M
0
26292
0.00
D
2028-02-07
Common Stock
26292
774708
D
The transactions occurred pursuant to a written trading plan dated November 29, 2017, meeting the requirements of Rule 10b5-1(c) with these sales hitting an established sales price trigger of $3.25 per share.
Following the sales on February 21, 2019 and February 22, 2019, the reporting person continues to beneficially own 25,000 shares of the company's common stock. The reporting person also holds stock options to acquire 2,448,178 shares of common stock, of which approximately 31% are vested, and restricted stock units representing an additional 931,999 shares of common stock subject to forfeiture restrictions.
Vests 25% on the first anniversary of the date of grant and 1/48th of the entire award monthly on the vesting date anniversary for 36 months, subject to acceleration as set forth in the Incentive Plan and the reporting person's Employment Agreement with the Company.
/s/ Joshua Weingard, as Attorney-in-Fact for Joseph Slattery
2019-02-25